COX

Cyclooxygenase (COX) inhibitors block the first committed step in prostaglandin synthesis from arachidonic acid. COX-1 is expressed in most tissues, whereas COX-2 is induced by cytokines and growth factors during inflammation. In 1971, inhibition of prostaglandin synthesis was proposed as the mechanism of action of aspirin-like drugs. Crystal structures of COX-2 with bound inhibitors, reported in 1996, explained the structural basis of COX-2 selectivity. Nonsteroidal anti-inflammatory drugs (NSAIDs) in this category include indomethacin, ibuprofen and etodolac, which differ in their preference for the two isoforms. Licofelone inhibits both COX and 5-lipoxygenase (5-LOX), two branches of arachidonic acid metabolism. Acetaminophen, also known as paracetamol, is listed for research on prostaglandin signaling, pain and fever.

3 Items

  • Fexofenadine HCl
    Cat. No.
    A11859

    Fexofenadine HCl

    Synonyms: Allegra

    Fexofenadine HCl is an antihistamine that inhibits Cox-1, Cox-2, and is a histamine H1 receptor agonist

    5 mg
    $30.00
    10 mg
    $40.00
    All 6 sizes
  • Lobeglitazone
    Cat. No.
    A24137

    Lobeglitazone

    Lobeglitazone is a novel thiazolidinedione-class compound and an orally active dual agonist of peroxisome proliferator-activated receptors (PPARs), with EC₅₀ values of 137.4 nM for PPARγ and 546.3 nM for PPARα. In addition to its metabolic effects, Lobeglitazone functions as an inhibitor of multiple pro-inflammatory and pro-fibrotic signaling pathways, including ERK, JNK, Smad, and NF-κB. Lobeglitazone exhibits a broad range of pharmacological activities, including anti-inflammatory, anti-diabetic, anti-fibrotic, and anti-atherosclerotic effects. These properties make it a promising candidate for therapeutic research in metabolic syndrome, type 2 diabetes, cardiovascular disease, and fibrosis-related conditions.

    5 mg
    $90.00
    10 mg
    $155.00
    All 4 sizes
  • Lobeglitazone sulfate
    Cat. No.
    A24240

    Lobeglitazone sulfate

    Lobeglitazone sulfate is a novel thiazolidinedione and an orally active agonist of peroxisome proliferator-activated receptors (PPARs), with EC50 values of 137.4 nM for PPARγ and 546.3 nM for PPARα. It also acts as an inhibitor of the ERK/JNK/Smad/NF-κB signaling pathways. Lobeglitazone sulfate exhibits anti-inflammatory, anti-diabetic, anti-fibrotic, and anti-atherosclerotic activities, supporting its potential in the treatment of metabolic and inflammatory diseases.

    5 mg
    $270.00
    10 mg
    $465.00
    All 4 sizes

3 Items

Added to your cart

View Cart Checkout

    Loading...